Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen M Ginn

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cell Host & Microbe|June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Cell Host & Microbe|September 10, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Nature Methods|June 20, 2017
High-speed fixed-target serial virus crystallographyPhilip Roedig, Helen M Ginn, Tim Pakendorf, et al.
Theranostics|January 6, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Cell Host & Microbe|December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variantsChang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cell Host & Microbe|June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Cell Host & Microbe|September 10, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Nature Methods|June 20, 2017
High-speed fixed-target serial virus crystallographyPhilip Roedig, Helen M Ginn, Tim Pakendorf, et al.
Theranostics|January 6, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Cell Host & Microbe|December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variantsChang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Pageof 4